Medical beauty
Medical beautyinternational patient acquisition
Dermatology, aesthetic clinics, and cosmetic surgery attracting international patients. KHIDI's 2025 statistics report 2.01 million foreign medical visitors to South Korea, with Japanese patients accounting for 29.8% and dermatology and beauty-related visits representing 62.9%. Source: KHIDI, 2025.
Entry requirements
- Named owner for foreign-language consultation, consent, and aftercare
- Established pricing, cancellation, refund, and complaint processes
- Medical advertising compliance and foreign-patient registration confirmed
- Operating capacity to accept additional qualified consultations
Key barriers
- Building a high-trust pre-consultation flow that matches patient LTV
- Medical advertising regulations and permitted claim standards in Japan and Korea
- Designing the discovery-to-booking path across local search, reviews, and community
- Standardizing inquiry response, booking handoff, and no-show prevention
RIVACTA execution approach
- 01SEO and GEO content built around local search demand and comparison intent
- 02Trust page structure covering reviews, pricing, recovery, and FAQ
- 03Inquiry response, booking handoff, and aftercare operations baseline
- 04Search advertising execution within medical advertising regulatory limits
KPI framework
- 01
Qualified native-language consultation inquiries
- 02
Inquiry-to-booking and booking-to-treatment conversion
- 03
Patient acquisition cost against treatment lifetime value
- 04
Repeat visit and referral rate after aftercare
Frequently Asked Questions
- Can you guarantee patient volume or medical outcomes?
- No. Medical and regulatory claims are off-limits; we structure compliant acquisition and defer all medical and clinical judgment to your licensed reviewer.
- How do you handle medical advertising regulations?
- We adapt messaging to local medical advertising rules and flag restricted claims, which your designated reviewer or counsel must approve before publishing.
- What does a medical-beauty engagement actually cover?
- Market readiness, compliant positioning, and qualified-inquiry acquisition — not clinical advice or guaranteed treatment results.
Regulatory notice
Under Japanese law, this industry is subject to strict licensing requirements and advertising-expression rules. Before contracting, RIVACTA reviews license and permit evidence, advertising expression, and any past administrative actions. Final responsibility for expression rests with the advertiser.
Under the Medical Care Act, medical advertising guidelines, and the Act against Unjustifiable Premiums and Misleading Representations, claims of guaranteed efficacy or safety, comparative superiority, before/after imagery, testimonials, and omitted risk disclosure are reviewed individually.
Don't see your industry?
We confirm customer acquisition readiness and market direction first. A fit call reviews your current stage.